AzTrials
AzTrials

DizzinessQEV-FRNCT04117620

Validity of the French Version of the Child's Vestibular Disorder Symptoms Questionnaire

An observational study of Dizziness, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire. Read more about this study

Who is it for?
Ages 7 to 17 years
Conditions the study is for
Dizziness
What is being tested?
Pediatric Vestibular Symptom Questionnaire
How many people
85 participants
Where
1 siteFrance
Study dates
28 Apr 2020to 28 Apr 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients followed by the department of otolaryngology and cervico-facial surgery of Necker-Enfants Malades hospital and siblings for the control subjects.

Who may be able to join

  • Non-opposition of the holders of parental authority and the subject to participation in the study
  • Subjects between 7 and 17 years of age
  • Patients : patients followed in the clinic at Necker Hospital in pediatric department of otolaryngology and cervico-facial surgery and presenting with dizziness without associated ophthalmological or neurological disorder.
  • Controls : subject with no vestibular deficiency, symptoms of balance disorder, migraine, otological pathology or ophthalmological disorder at the time of inclusion or background.

Who cannot join

  • Absence of diagnosis after etiological assessment.

Trial locations and contacts

1 site in 1 country.

France1 site
  • AP-HP, Hôpital Necker-Enfants Malades

    Paris, 75015

Other trials in France

About this study

There is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire.

Read the detailed description

Balance disorders are the most common cause of dizziness in children with a prevalence of 0.7 to 15%. Vestibular migraine, benign paroxysmal positional vertigo of the child, post-concussion dizziness as a result of cranial trauma, and viral vestibular neuritis are the most common causes. However, these disorders are often undiagnosed in children as many doctors may attribute these symptoms to behavioural disorders or clumsiness. This is probably because of the difficulty children may have in expressing or describing their dizziness symptoms without specific questioning, but also because of the tendency of children to accept the terminology that an adult offers them or even tend to cling to their parents when they experience a balance disorder or vertigo. Vestibular disorders can also have secondary psychological symptoms with an impact on school learning and quality of life. A precise interrogation to check the symptoms, to look for the triggers and to trace the installation of the symptoms is fundamental to diagnose and make a therapeutic decision. Thus, it is very important to help the child express his or her feelings by proposing different descriptions and formulations to determine the etiology and diagnosis. While a number of international questionnaires validated and translated into French exist in the adult to assess the presence, severity and impact of vestibular symptoms, there is currently no score in French for evaluating disorders of the child's balance. Only one questionnaire was validated in the child in English in 2016, the " Pediatric Vestibular Symptom Questionnaire ". The objective of the research is to validate the French translation of this questionnaire.

Conditions
Dizziness
Being tested
Pediatric Vestibular Symptom Questionnaire
Keywords
Pediatric vestibular symptom, Pediatric vestibular symptom questionnaire in french
Medical subject headings
Dizziness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pediatric Vestibular Symptom QuestionnaireOther

    Also called Patient questionnaire

    Subjects respond to the translated questionnaire twice with 15 days interval

Study groups in NCT04117620
Study groupRoleWhat they receive
PatientsPatients from 7 to 17 years of age with vestibular deficiency.
Receives: Other: Pediatric Vestibular Symptom Questionnaire
ControlsSubjects from 7 to 17 years of age without vestibular deficiency
Receives: Other: Pediatric Vestibular Symptom Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reproducibility

    Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test.

    Measured: 1 year

  2. Consistency reliability test

    Measure of efficiency. Comparison of questionnaires completed by patients and controls.

    Measured: 1 year

  3. Item-total Pearson correlation

    Measure of efficiency. Comparison of questionnaires completed by patients and controls.

    Measured: 1 year

  4. Principal components analysis

    Measure of efficiency. Comparison of questionnaires completed by patients and controls.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2019
  2. Study start28 Apr 2020
  3. Primary completion28 Apr 2021
  4. Study completion28 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
85 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04117620
Sponsor's protocol ID
APHP190616
Other IDs
ID RCB : 2019-A00364-53
Acronym
QEV-FR
Status last verified
Sep 2025
First submitted
3 Oct 2019
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rigal T, Parodi M, Brisse F, Denoyelle F, Loundon N, Simon F. Translation and validation of the PVSQ and DHI-PC questionnaires for pediatric dizziness. Eur Ann Otorhinolaryngol Head Neck Dis. 2024 Jan;141(1):5-12. doi: 10.1016/j.anorl.2023.05.001. Epub 2023 May 22.

    PubMed 37225531

Questions about this trial

What is this clinical trial studying?

An observational study of Dizziness, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reproducibility (time frame: 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04117620, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in